Literature DB >> 19412916

The QuantumCor device for treating mitral regurgitation: an animal study.

Ramil Goel1, Thomas Witzel, Duane Dickens, Patricia A Takeda, Richard R Heuser.   

Abstract

OBJECTIVES: The mitral annular contraction achieved could help reduce mitral regurgitation (MR), and with appropriate modifications, be applied to human subjects providing a potentially effective percutaneous method of valve repair.
BACKGROUND: MR is an important source of morbidity and is an independent predictor of mortality. A variety of percutaneous approaches are being developed to address this issue. We introduce a novel potential method utilizing radiofrequency (RF) energy to heat and shrink the mitral valve annulus in an animal model.
METHODS: In open-heart procedures in 16 healthy sheep (six with naturally occurring MR), we used a malleable probe (QuantumCor, Lake Forest, CA) that conforms to the annular shape to deliver RF energy via a standard generator to replicate a surgical mitral annular ring. Seven sheep were followed chronically and their mitral annulus dimensions measured serially.
RESULTS: All sheep underwent intracardiac echocardiography or direct circumferential measurement of the mitral annulus before and after RF therapy. RF therapy was administered in less than 4 min in each case, and the mean anteroposterior (AP) annular distance was reduced by a mean of 23.8% (AP diameter reduction 5.75 +/- 0.86 mm, P < 0.001) acutely. In the six sheep with nonischemic MR, regurgitation was eliminated. Acute histopathology (HP) demonstrated no damage to the leaflets, coronary sinuses, or coronary arteries. At the end of the intended 6-month period of the chronic part of the study, four of the seven animals survived. The four treatment animals showed significant reductions in mitral A-P dimension, with a percent diameter reduction of 26.4% (AP diameter reduction 7 +/- 2.3 mm).
CONCLUSION: The application of RF directly to heat the mitral annulus has resulted in sustained contraction of the annulus in this limited preclinical animal study. With further study and possible modifications, it holds promise for future application in human subjects with MR. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19412916     DOI: 10.1002/ccd.21868

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

Review 1.  Devices for mitral valve repair.

Authors:  Paolo Denti; Francesco Maisano; Ottavio Alfieri
Journal:  J Cardiovasc Transl Res       Date:  2014-01-23       Impact factor: 4.132

Review 2.  Percutaneous approaches to mitral valve regurgitation.

Authors:  S C Bertog; J Franke; D H Steinberg; N Wunderlich; H Sievert
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

3.  Computed tomography for planning and postoperative imaging of transvenous mitral annuloplasty: first experience in an animal model.

Authors:  Simon H Sündermann; Sonja Gordic; Robert Manka; Nikola Cesarovic; Volkmar Falk; Francesco Maisano; Hatem Alkadhi
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-15       Impact factor: 2.357

4.  Mitral transcatheter technologies.

Authors:  Francesco Maisano; Nicola Buzzatti; Maurizio Taramasso; Ottavio Alfieri
Journal:  Rambam Maimonides Med J       Date:  2013-07-25

5.  What Is the Next Generation of Transcatheter Mitral Valve Repair Devices?

Authors:  Mi Chen; Lizhong Sun
Journal:  Front Cardiovasc Med       Date:  2021-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.